Advertisement

FDA requires opioid makers to develop doctor training

By Associated Press  |  September 29, 2017

The agency notified 74 manufacturers of so-called immediate-release opioids that their drugs will now be subject to the tougher requirements, although doctors would not be compelled to take part in the training.

Groups seek ban on high-dose opioids citing overdose danger

By Associated Press  |  August 31, 2017

Safety advocates and state health officials are formally calling on the Food and Drug Administration to ban high-dose opioid painkillers to prevent accidental overdose deaths among patients and people who abuse drugs.

U.S. clears first 'living drug' for childhood leukemia

By Associated Press  |  August 30, 2017

Opening a new era in cancer care, the Food and Drug Administration approved the first treatment that genetically engineers patients' own blood cells into an army of assassins to seek and destroy childhood leukemia.

FDA gives Invacare permission to ramp up manufacturing

By Chuck Soder  |  July 26, 2017

Invacare is finally free to build as many wheelchairs as it pleases. The U.S. Food and Drug Administration has given the company permission to ramp up manufacturing at its Elyria, Ohio, plant.

Data Points: Growth in generics doing little to curb drug prices

Data Points: Growth in generics doing little to curb drug prices

By Modern Healthcare  |  July 10, 2017

The Food and Drug Administration in June took steps to increase competition by posting a list of branded drugs that are not protected by patent and are not facing looming generic drug rivals. The agency will fast-track its review of generic drug applications.

Advertisement
X

Subscribe and SAVE 50%

View our best offer
Subscribe to Print